1. Home
  2. DNLI vs MANU Comparison

DNLI vs MANU Comparison

Compare DNLI & MANU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$23.11

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Manchester United Ltd.

MANU

Manchester United Ltd.

HOLD

Current Price

$22.67

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNLI
MANU
Founded
2013
1878
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
DNLI
MANU
Price
$23.11
$22.67
Analyst Decision
Strong Buy
Analyst Count
14
0
Target Price
$34.33
N/A
AVG Volume (30 Days)
1.9M
214.8K
Earning Date
05-06-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$408.85
$16.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.58
$14.59
52 Week High
$27.30
$24.22

Technical Indicators

Market Signals
Indicator
DNLI
MANU
Relative Strength Index (RSI) 45.21 56.48
Support Level $18.27 $21.14
Resistance Level $23.27 $22.94
Average True Range (ATR) 1.38 0.52
MACD -0.39 -0.03
Stochastic Oscillator 17.58 86.11

Price Performance

Historical Comparison
DNLI
MANU

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

About MANU Manchester United Ltd.

Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.

Share on Social Networks: